Skip to main content

Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.

Publication ,  Journal Article
Vo, QN; Geradts, J; Gulley, ML; Boudreau, DA; Bravo, JC; Schneider, BG
Published in: J Clin Pathol
September 2002

AIMS: It has been shown previously (by immunohistochemistry) that gastric adenocarcinomas harbouring Epstein-Barr virus (EBV) frequently lose p16 protein. This study aimed to examine the mechanisms of inactivation of the CDKN2A gene and correlate the results with clinicopathological features. METHODS: Methylation specific polymerase chain reaction was used to detect CDKN2A promoter methylation in gastric adenocarcinomas from American patients. In addition, immunohistochemistry was used to detect the loss of the p16 protein and in situ hybridisation was used to detect the presence of EBV. The tumours were also analysed for the presence of microsatellite instability. RESULTS: Eleven (10%) of 107 tumours harboured EBV in the malignant cells. In gastric cancers without EBV, 32% exhibited CDKN2A promoter methylation and 26% had p16 protein loss. In contrast, 91% of the tumours containing EBV had CDKN2A promoter methylation (p = 0.0003) and 90% showed p16 protein loss (p = 0.0001). The presence of EBV was also associated with male sex (p = 0.03) and was more common in tumours from Texas Hispanics than from non-Hispanic whites or African-Americans (p = 0.01). EBV was not associated with microsatellite instability, histological subtype, stage, or grade of the tumour, or age or survival time of the patient. CONCLUSIONS: The presence of EBV in gastric adenocarcinomas is strongly associated with CDKN2A inactivation by promoter methylation. In addition, these findings suggest that there are ethnic differences in tumour virology and pathogenesis.

Duke Scholars

Published In

J Clin Pathol

DOI

ISSN

0021-9746

Publication Date

September 2002

Volume

55

Issue

9

Start / End Page

669 / 675

Location

England

Related Subject Headings

  • United States
  • Stomach Neoplasms
  • Promoter Regions, Genetic
  • Pathology
  • Middle Aged
  • Microsatellite Repeats
  • Male
  • Humans
  • Hispanic or Latino
  • Herpesvirus 4, Human
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vo, Q. N., Geradts, J., Gulley, M. L., Boudreau, D. A., Bravo, J. C., & Schneider, B. G. (2002). Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol, 55(9), 669–675. https://doi.org/10.1136/jcp.55.9.669
Vo, Q. N., J. Geradts, M. L. Gulley, D. A. Boudreau, J. C. Bravo, and B. G. Schneider. “Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.J Clin Pathol 55, no. 9 (September 2002): 669–75. https://doi.org/10.1136/jcp.55.9.669.
Vo QN, Geradts J, Gulley ML, Boudreau DA, Bravo JC, Schneider BG. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol. 2002 Sep;55(9):669–75.
Vo, Q. N., et al. “Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.J Clin Pathol, vol. 55, no. 9, Sept. 2002, pp. 669–75. Pubmed, doi:10.1136/jcp.55.9.669.
Vo QN, Geradts J, Gulley ML, Boudreau DA, Bravo JC, Schneider BG. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol. 2002 Sep;55(9):669–675.

Published In

J Clin Pathol

DOI

ISSN

0021-9746

Publication Date

September 2002

Volume

55

Issue

9

Start / End Page

669 / 675

Location

England

Related Subject Headings

  • United States
  • Stomach Neoplasms
  • Promoter Regions, Genetic
  • Pathology
  • Middle Aged
  • Microsatellite Repeats
  • Male
  • Humans
  • Hispanic or Latino
  • Herpesvirus 4, Human